214390 — Kyongbo Pharmaceutical Co Balance Sheet
0.000.00%
Last trade - 00:00
HealthcareSpeculativeSmall Cap
- KR₩178bn
- KR₩250bn
- KR₩216bn
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 6,769 | 20,983 | 4,290 | 6,348 | 4,477 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 52,641 | 52,727 | 47,909 | 50,799 | 56,858 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 124,176 | 138,192 | 111,166 | 116,326 | 135,902 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 90,391 | 90,100 | 95,677 | 93,919 | 96,073 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 237,817 | 253,239 | 236,979 | 240,545 | 266,305 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 83,815 | 93,764 | 88,814 | 95,569 | 118,261 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 88,653 | 97,182 | 91,278 | 96,841 | 121,924 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 149,164 | 156,057 | 145,701 | 143,704 | 144,381 |
Total Liabilities & Shareholders' Equity | 237,817 | 253,239 | 236,979 | 240,545 | 266,305 |
Total Common Shares Outstanding |